BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$803M |
| 2 |
iShares MSCI South Korea ETF
EWY
|
+$683M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$676M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$612M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$570M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.92B |
| 2 |
Meta Platforms (Facebook)
META
|
+$899M |
| 3 |
Amazon
AMZN
|
+$705M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$698M |
| 5 |
GE Vernova
GEV
|
+$545M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Financials | 7.92% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Healthcare | 6.49% |
| 5 | Industrials | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNA
4176
Atrium Therapeutics
RNA
$191M
| $111K | ﹤0.01% |
+8,267
| New | +$116K |
|
4177
AngioDynamics
ANGO
$605M
| $110K | ﹤0.01% |
9,714
+1,317
| +16% | +$14.3K |
|
|
YHNA
4178
YHN Acquisition I Ltd
YHNA
$46.8M
| $110K | ﹤0.01% |
+10,284
| New | +$110K |
|
4179
Strive Inc
ASST
$930M
| $110K | ﹤0.01% |
+10,992
| New | +$137K |
|
|
JMIA
4180
Jumia Technologies
JMIA
$708M
| $110K | ﹤0.01% |
15,958
-105,688
| -87% | -$1.06M |
|
|
XRPNW
4181
Armada Acquisition Corp II Warrant
XRPNW
$8.74M
| $110K | ﹤0.01% |
183,174
| – | – |
|
|
NBTX
4182
Nanobiotix
NBTX
$1.92B
| $110K | ﹤0.01% |
3,559
-41
| -1% | -$1.08K |
|
4183
Xperi
XPER
$364M
| $110K | ﹤0.01% |
19,574
-572
| -3% | -$3.31K |
|
4184
PUT
Cheesecake Factory
CAKE
$5.03B
| $110K | ﹤0.01% |
+20
| New | +$1.19K |
|
|
CHCT
4185
Community Healthcare Trust
CHCT
$536M
| $109K | ﹤0.01% |
6,886
-225
| -3% | -$3.79K |
|
4186
Waterstone Financial
WSBF
$371M
| $109K | ﹤0.01% |
6,036
-2,106
| -26% | -$37.4K |
|
|
BZUN
4187
Baozun
BZUN
$179M
| $109K | ﹤0.01% |
45,499
+3,732
| +9% | +$9.71K |
|
4188
Fulcrum Therapeutics
FULC
$241M
| $109K | ﹤0.01% |
14,147
+3,625
| +34% | +$33.6K |
|
|
NAVN
4189
Navan Inc
NAVN
$6.76B
| $108K | ﹤0.01% |
8,130
+484
| +6% | +$5.75K |
|
4190
i3 Verticals
IIIV
$419M
| $107K | ﹤0.01% |
4,806
-379
| -7% | -$8.82K |
|
|
NOA
4191
North American Construction
NOA
$357M
| $107K | ﹤0.01% |
7,967
+7,207
| +948% | +$110K |
|
4192
Malibu Boats
MBUU
$548M
| $107K | ﹤0.01% |
4,140
-137
| -3% | -$4.09K |
|
|
MBAVW
4193
DELISTED
M3-Brigade Acquisition V Corp Warrant
MBAVW
| $106K | ﹤0.01% |
393,588
| – | – |
|
4194
Peoples Financial Services
PFIS
$718M
| $106K | ﹤0.01% |
1,989
-79
| -4% | -$4.17K |
|
4195
Radware
RDWR
$983M
| $106K | ﹤0.01% |
4,026
-44,375
| -92% | -$1.1M |
|
4196
Kura Sushi USA
KRUS
$581M
| $106K | ﹤0.01% |
1,517
+116
| +8% | +$7.78K |
|
4197
Unisys
UIS
$252M
| $106K | ﹤0.01% |
51,015
+37,024
| +265% | +$92.9K |
|
|
FFIC
4198
DELISTED
Flushing Financial
FFIC
| $105K | ﹤0.01% |
6,866
-1,057
| -13% | -$16.5K |
|
4199
Cable One
CABO
$237M
| $105K | ﹤0.01% |
1,153
-31
| -3% | -$3.03K |
|
|
GSRFR
4200
GSR IV Acquisition Corp Rights
GSRFR
| $105K | ﹤0.01% |
52,278
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Financial Markets held 6,247 positions worth $206B, down 6.7% from $221B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q1 2026 filing shows 521 new, 2,339 increased, 2,351 reduced and 443 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M. The largest sale was Apple, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q1 2026 buy was Vanguard Long-Term Corporate Bond ETF: 1,501,253 shares worth $112M.
- BNP Paribas Financial Markets added most to Oracle in Q1 2026, an estimated $803M increase.
- BNP Paribas Financial Markets's biggest Q1 2026 reduction was Apple, cutting an estimated $1.92B.
- BNP Paribas Financial Markets fully exited Flutter Entertainment in Q1 2026, selling an estimated $332M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $206B portfolio in Q1 2026.
- BNP Paribas Financial Markets opened 521 new positions and closed 443 in Q1 2026.
- BNP Paribas Financial Markets's portfolio value fell 6.7% quarter-over-quarter to $206B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.